Why the Next Billion Dollar Longevity Opportunity May Not Be a ProductEntreprenuer
Longevity has no shortage of products, science, capital or consumer interest. The bottleneck is translation: getting promising science validated, understood by clinicians, implemented responsibly and ultimately to patients.
Posted from: this blog via Microsoft Power Automate.
Comments